RPL13P4

Across TCGA pan-cancer cohorts, RPL13P4 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RPL13P4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL13P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL13P4 is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

KIRC, STAD, and COAD are the cancer types where RPL13P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL13P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.068	.001	8	view →
STAD	Male	III,IV	+0.308	.011	4	view →
COAD	All	All	+0.102	.005	4	view →
LIHC	All	II,III,IV	+0.036	.016	3	view →
UCEC	All	IV	−0.310	.004	2	view →
THCA	Female	II,III,IV	−0.160	.021	2	view →
HNSC	Male	III,IV	+0.059	.027	2	view →
LUAD	All	All	+0.188	.024	1	view →
THCA	Male	II,III,IV	+0.087	.044	1	view →
KIRP	All	All	−0.049	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 9 lineages.

RPL13P4–KIRC

Open the KIRC breakdown →